Fidia
Hyaluronic acid-based therapies for regenerative and pharmaceutical applications.
About the company
Fidia is a pharmaceutical company with a long-standing focus on hyaluronic acid research and its medical applications. On its Austrian website, the company highlights its work in innovation, regenerative care and the development of therapeutic solutions based on the regenerative properties of hyaluronic acid.
According to Fidia, its research into hyaluronic acid dates back to the 1950s. The company develops and produces hyaluronic acid fractions with different molecular weights and specific physicochemical properties for different medical uses, including wound care and intra-articular applications. Fidia also reports ongoing research activity across more than 50 projects and collaboration with leading research centers and universities.
What can you expect at the Ski World Cup?
Presentation of Fidia’s scientific approach to hyaluronic acid and regenerative care
Insights into different hyaluronic acid fractions and their medical applications
Discussion of clinical use in areas such as wound management and intra-articular treatment
Information on current research and development activities in hyaluronic acid-based solutions
Opportunity for professional exchange on regenerative medicine, translational research and clinical practice
Your on-site contact person:
Harald Meller
National Sales Manager
Austria & Germany
Expert Bar Talks
Get to know Fidia better at our “Expert Bar Talks” and discuss possible applications in your everyday work in a relaxed atmosphere.
Date: March 19, 2026, 4:00–8:00 p.m.